Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2003
10/09/2003WO2003082873A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082863A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082857A2 Lansoprazole polymorphs and processes for preparation thereof
10/09/2003WO2003082854A1 1-n-aminobenzimidazole derivatives
10/09/2003WO2003082841A1 5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as ptpase 1b inhibitors
10/09/2003WO2003082839A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082817A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003WO2003082813A2 Improvements in pharmaceutical compositions
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082807A2 Amino acids with affinity for the alpha-2-delta-protein
10/09/2003WO2003082798A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
10/09/2003WO2003082792A1 Process for synthesis of trans-alkenoic acid, use thereof
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082359A1 Tissue treatment
10/09/2003WO2003082345A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
10/09/2003WO2003082344A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
10/09/2003WO2003082343A1 Drugs for treating liver diseases with the use of hollow protein nanoparticles
10/09/2003WO2003082322A1 A method of modulating cellular activity
10/09/2003WO2003082321A1 Dental viscous pharmaceutical containing basic fibroblast growth factor
10/09/2003WO2003082312A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
10/09/2003WO2003082307A1 Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies
10/09/2003WO2003082306A1 Lactobacillus iners for the enhancement of urogenital health
10/09/2003WO2003082300A1 Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082277A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003WO2003082274A1 Angiogenesis inhibitors
10/09/2003WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003082196A2 Combination therapy using trefoil peptides
10/09/2003WO2003082191A2 Substituted 2,3-diphenyl pyridines
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003WO2003082027A1 Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
10/09/2003WO2003049804A3 Treatment of genitourinary tract disorders
10/09/2003WO2003045917A3 Ccr-3 receptor antagonists vii
10/09/2003WO2003013534A3 Methods for the treatment of cancer with irinotecan based on cyp3a5
10/09/2003WO2003013533A3 Methods for improved treatment of cancer with irinotecan based on mrp1
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002080939A3 Ionene polymers and their use as antimicrobial agents
10/09/2003WO2002078682A3 Estrogen replacement therapy
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002074056A3 Allosteric adenosine receptor modulators
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
10/09/2003WO2002055063A3 Fumaric acid amides
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002026245A3 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
10/09/2003WO2002016434A9 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
10/09/2003US20030191332 Prevention of neutrophil recruitment
10/09/2003US20030191296 Erythromycin derivative having novel crystal structures and processes for their production
10/09/2003US20030191186 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
10/09/2003US20030191181 4-[(8-Ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome P450RAI inhibitory activity
10/09/2003US20030191180 Pharmaceutical compositions
10/09/2003US20030191178 Therapy for vision defects; hypotensive agents; respiratory system disorders
10/09/2003US20030191176 Stable hydrate of a muscarinic receptor antagonist
10/09/2003US20030191175 Indole sPLA2 inhibitors
10/09/2003US20030191174 Novel bicyclic compounds
10/09/2003US20030191170 Central nervous system disorders; antiallergens; respiratory system disorders
10/09/2003US20030191167 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191159 Antisecretory agents; antiulcer agents; adjust absorption
10/09/2003US20030191157 Injections
10/09/2003US20030191137 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
10/09/2003US20030191126 Psychological disorders; antidepressants
10/09/2003US20030191123 2-amino-benzoxazinone derivatives for the treatment of obesity
10/09/2003US20030191122 Antidepressants; Alzheimer's disease; Parkinson's disease; central nervous system disorders
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191116 Gastrin and cholecystokinin receptor ligands (III)
10/09/2003US20030191114 Binding to ligand; induce signals
10/09/2003US20030191103 Hormone replacement therapy
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003US20030191092 MMP inhibitors
10/09/2003US20030191079 Methods for treating and preventing infectious disease
10/09/2003US20030191075 Modulation of gene expression of nucleic acids; sterol binding to oligonucleotides
10/09/2003US20030191074 Antibody therapy; immobilization
10/09/2003US20030191070 Medical composition kit for treating lesioned abnormal tissue
10/09/2003US20030191067 Hepatitis C inhibitor tri-peptides
10/09/2003US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders
10/09/2003US20030191053 Cyclic peptide derivative
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190685 Bind to Tumor Necrosis Factor(TNF)-Related Apoptosis Inducing Ligand (TRAIL) receptors ; used in the prevention and treatment of cancers and other proliferative disorders
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190344 Animal feed or feed additive as performance enhancer or appetite enhancer for live stock
10/09/2003US20030190334 1S-(1 alpha ,3 alpha ,4 beta ))-2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)-2 -methylenecyclopentyl)-6H-puri n-6-one to treat hepatitis B virus infection
10/09/2003US20030190332 Engineered viral particle containing a group of co-expressed viral proteins or portions expressed in an edible plant material, adminstering such plant material containing viral vaccine to the gastrointenial mucosa of the patient
10/09/2003US20030190309 Novel probiotics for pet food applications
10/09/2003CA2481214A1 Viscous preparation for dental use containing basic fibroblast growth factor
10/09/2003CA2480890A1 1-n-aminobenzimidazole derivatives
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
1 ... 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 ... 1258